AUSTIN, Texas--(BUSINESS WIRE)--MindWalk Holdings Corp.™ (“MindWalk,” “Company,” “we” or “us”) (Nasdaq: HYFT), a Bio-Native AI company, today ...
Lead clinical-stage program, OLN324, is a higher potency VEGF/Ang2 bispecific antibody in a fully-recruited head-to-head study versus faricimab in wet AMD and DME, with topline data expected Q1 2026 ...
LAS VEGAS (FOX5) — The Lou Ruvo Center for Brain Health is offering a free, 8-week exploration art class for people living with dementia. Opening Minds through Art (OMA) is an award-winning, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback